Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.

Yves Allenbach Yurdagul UzunhanSégolène ToquetGaëlle LerouxLaure GallayAlicia MarquetAlain MeyerConstance GuillaudNicolas LimalFrédéric GagnadouxBaptiste HervierRaphaël BorieChristophe DelignyBenjamin TerrierAlice BerezneSylvain AudiaNicolas ChamptiauxHervé DevilliersNicol VoermansElizabeth DiotAmélie ServettazThierry MarhadourVincent CastelainSébastien HumbertClaire Blanchard-DelaunayNathalie TieuliePierre CharlesMagdalena GerinArsène MekinianPascaline PriouJean Claude MeuriceAbdellatif TaziVincent CottinMakoto MiyaraBenjamin GrangeDominique Israël-BietSophie Phin-HuynhCamille BronLuc De Saint MartinNicole FabienKubéraka MariampillaiHilario NunesOlivier Benvenistenull null

Published in: Neurology (2020)

Anti-MDA5+ patients have a systemic syndrome distinct from other patients with myositis. Three subgroups with different prognosis exist.

Keyphrases

end stage renal disease
interstitial lung disease
chronic kidney disease
newly diagnosed
ejection fraction
breast cancer cells
peritoneal dialysis
systemic sclerosis
systemic lupus erythematosus
case report
patient reported outcomes
cell proliferation
signaling pathway